Considering the synergistic effects of VCAM-1 in IBD and CRC via its multiple cell-to-cell signalling mechanisms, the potential of the protein as a multi-functional drug target is an intriguing platform for precision nanomedicines in colorectal disease treatment. The gene discussed is VCAM1; the disease is colorectal carcinoma.